Biofrontera AG Sponsored ADR 5Y Total Assets Growth (CAGR)

5Y Total Assets Growth (CAGR) of BFAGY for past 10 years: annual, quarterly and twelve month trailing (TTM) including 5Y Total Assets Growth (CAGR) growth rates and interactive chart.


Highlights and Quick Summary

  • Annual 5Y Total Assets Growth (CAGR) for 2021 was 5.63% (a -63.89% decrease from previous year)
  • Annual 5Y Total Assets Growth (CAGR) for 2021 was 15.59% (a 142.08% increase from previous year)
  • Annual 5Y Total Assets Growth (CAGR) for 2020 was 6.44% (a -73.05% decrease from previous year)
Visit stockrow.com/BFAGY for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical 5Y Total Assets Growth (CAGR) of Biofrontera AG Sponsored ADR

Most recent 5Y Total Assets Growth (CAGR)of BFAGY including historical data for past 10 years.

Interactive Chart of 5Y Total Assets Growth (CAGR) of Biofrontera AG Sponsored ADR

Biofrontera AG Sponsored ADR 5Y Total Assets Growth (CAGR) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2021 5.63%
2020 6.44%
2019 25.62%
2018 12.23%
2017 -19.29%
2016 -17.47%

Business Profile of Biofrontera AG Sponsored ADR

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic